Treatment group demographics
| Variable | Antiplatelet Drugs: Before and After | Antiplatelet Drugs: After Only | No Antiplatelet Drugs | P | Statistical Test |
|---|---|---|---|---|---|
| Women | 188/258 (72.9) | 69/86 (80.2) | 20/25 (80.0) | .3285 | X2 (2 × 3) |
| Men | 70/258 (27.1) | 17/86 (19.8) | 5/25 (20.0) | .3285 | X2 (2 × 3) |
| Age, y | 55.68 | 53.45 | 57.80 | .1922 | One-way ANOVA |
| Diameter of first framing coil, mm | 6.3 | 7.0 | 7.3 | .1834 | One-way ANOVA |
| Prolapsed coil | 30/258 (11.6) | 8/86 (9.3) | 3/25 (12.0) | .7840 | X2 (2 × 3) |
| Coated coils | 64/258 (24.8) | 10/86 (11.6) | 1/25 (4.0) | .0014* | X2 (2 × 3) |
| Balloon | 32/258 (12.4) | 8/86 (9.3) | 1/25 (4.0) | .3098 | X2 (2 × 3) |
| Stent (total) | 52/258 (20.2) | 6/86 (7.0) | 0/25 (0.0) | .0001* | X2 (2 × 3) |
Note:—Raw values are reported in each cell. Percentage of the population is in parentheses. ANOVA indicates analysis of variance.
* denotes statistically significant P value.